Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pirtobrutinib is a BTK inhibitor developed by Eli Lilly and Company in the Unite···【more】
Release date：2026-03-25Recommended：259
During treatment with pirtobrutinib, some side effects may occur, and these effe···【more】
Release date：2026-03-25Recommended：255
For Patients with Severe Renal Impairment(1). If the current dose is 200 mg once···【more】
Release date：2026-03-25Recommended：300
Pirtobrutinib is a non-covalent (reversible) Bruton's tyrosine kinase (BTK) ···【more】
Release date：2026-03-25Recommended：289
Enasidenib helps restore the normal differentiation of leukemia cells by inhibit···【more】
Release date：2026-03-24Recommended：199
The dosage and administration of enasidenib must strictly follow medical advice ···【more】
Release date：2026-03-24Recommended：191
The use of tepotinib must strictly adhere to the principle of individualized tre···【more】
Release date：2026-03-24Recommended：225
Side Effects of TepotinibPatients should schedule regular follow-ups during trea···【more】
Release date：2026-03-24Recommended：226
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA···【more】
Release date：2026-03-23Recommended：222
On January 17, 2025, Amgen announced that the U.S. Food and Drug Administration ···【more】
Release date：2026-03-23Recommended：239
KRAS mutations have long been considered a major challenge in cancer research, r···【more】
Release date：2026-03-23Recommended：206
Sotorasib is a KRASG12C inhibitor developed by Amgen. It received accelerated ap···【more】
Release date：2026-03-23Recommended：200
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
